Evaluation of Safety and Tolerability of Investigational Ocular Lubricants
NCT ID: NCT05888519
Last Updated: 2023-10-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
47 participants
INTERVENTIONAL
2023-07-24
2023-09-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Safety and Tolerability of Ocular Lubricants
NCT06571656
Study of Safety and Performance of a Novel Ocular Lubricant in Subjects With Dry Eye Disease
NCT06444516
Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease
NCT01459588
A Study of AL-38583 Ophthalmic Solution 0.05%, 0.010% Versus AL-38583 Vehicle for Dry Eye
NCT00893139
A Clinical Evaluation of an Investigational Lubricant Eye Gel (FID 115958D)
NCT01294956
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
FID123300/FID123301/FID122505
FID123300 ocular lubricant in Period 1, followed by FID12330 ocular lubricant in Period 2, followed by FID122505 ocular lubricant in Period 3, as randomized. For each period, the subject will receive one drop in each eye for one day. A 1-4 day washout will separate each period.
FID123300 ocular lubricant
Investigational ocular lubricant
FID123301 ocular lubricant
Investigational ocular lubricant
FID122505 ocular lubricant
Comparator ocular lubricant
FID123301/FID122505/FID123300
FID123301 ocular lubricant in Period 1, followed by FID122505 ocular lubricant in Period 2, followed by FID123300 ocular lubricant in Period 3, as randomized. For each period, the subject will receive one drop in each eye for one day. A 1-4 day washout will separate each period.
FID123300 ocular lubricant
Investigational ocular lubricant
FID123301 ocular lubricant
Investigational ocular lubricant
FID122505 ocular lubricant
Comparator ocular lubricant
FID122505/FID123300/FID123301
FID122505 ocular lubricant in Period 1, followed by FID123300 ocular lubricant in Period 2, followed by FID123301 ocular lubricant in Period 3, as randomized. For each period, the subject will receive one drop in each eye for one day. A 1-4 day washout will separate each period.
FID123300 ocular lubricant
Investigational ocular lubricant
FID123301 ocular lubricant
Investigational ocular lubricant
FID122505 ocular lubricant
Comparator ocular lubricant
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FID123300 ocular lubricant
Investigational ocular lubricant
FID123301 ocular lubricant
Investigational ocular lubricant
FID122505 ocular lubricant
Comparator ocular lubricant
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have dry eye symptoms;
Exclusion Criteria
* Active ocular infection or inflammation not associated with dry eye;
* History of ocular or intraocular surgery;
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Trial Lead, Dry Eye
Role: STUDY_DIRECTOR
Alcon Research, LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
George Street Eye Centre
Sydney, New South Wales, Australia
Ophthalmic Trials Australia
Teneriffe, Queensland, Australia
University of Melbourne, Department of Optometry and Vision Science
Carlton, Victoria, Australia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DEP918-E001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.